602 top medical experts on Primitive Neuroectodermal Tumors across 53 countries and 36 U.S. states, including 484 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Primitive Neuroectodermal Tumors: A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., neuroectodermal tumors, primitive, peripheral). This term is also occasionally used as a synonym for medulloblastoma. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Neuroepithelial Neoplasms (2,390) and Narrower Categories: Medulloblastoma (3,295), Peripheral Primitive Neuroectodermal Tumors (965).
  4. Clinical Trials ClinicalTrials.gov : at least 138 including 20 Active, 71 Completed, 25 Recruiting
  5. Synonyms: Ependymoblastoma,  Medulloepithelioma,  Primitive Neuroepithelial Tumors,  PNET,  Spongioblastoma


  

        

                    


    Computing Expert Listing ...

);